Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Facchini

Showing results (41-50 of 103) with videos related to

Pageof 11
Sort By:
Minerva Ginecologica|March 1, 1988
[Preoperative plasma levels of von Willebrand factor in patients with cervical carcinoma]A Gadducci, U Baicchi, B Del Bravo, et al.
Gynecologic Oncology|May 1, 1996
Prothrombin fragment F1+2 and thrombin-antithrombin III complex (TAT) plasma levels in patients with gynecological cancerA Gadducci, R Marrai, U Baicchi, et al.
Annali Di Ostetricia, Ginecologia, Medicina Perinatale|July 1, 1986
[Rational bases of surgery in the therapeutic strategy for ovarian cancer]V Facchini, A Gadducci, B Del Bravo, et al.
European Journal of Gynaecological Oncology|January 1, 1986
Combined evaluation of some tumor associated antigens in the monitoring of integrated surgical and chemotherapeutic treatment of epithelial ovarian cancerP Fioretti, A Gadducci, M Ferdeghini, et al.
The Journal of Nuclear Medicine and Allied Sciences|January 1, 1989
The serum concentrations of TAG-72 antigen measured with CA 72-4 IRMA in patients with ovarian carcinoma. Preliminary dataA Gadducci, M Ferdeghini, T Ceccarini, et al.
Gynecologic Oncology|June 1, 1994
Pretreatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD), and von Willebrand factor (vWF) in patients with ovarian carcinomaA Gadducci, U Baicchi, R Marrai, et al.
European Journal of Gynaecological Oncology|January 1, 1988
The association of ultrasonography and CA-125 test in the preoperative evaluation of ovarian carcinomaA Gadducci, P Capriello, T Bartolini, et al.
Journal of Chromatography. B, Biomedical Applications|November 4, 1994
Assay and single dose pharmacokinetics of a novel systemic acyl coenzyme A cholesterol O-acyltransferase inhibitor, RP 73163, in rat plasma using automated solid-phase extraction with high-performance liquid chromatographyG D Jones, T A Hoff, P E Gunraj, et al.
European Journal of Gynaecological Oncology|January 1, 1990
A comparison of the usefulness of serum measurements of CA 125, CA 50 and TATI in patients with malignant and benign gynecological pathologyA Gadducci, M Ferdeghini, V Facchini, et al.
European Journal of Gynaecological Oncology|January 1, 1990
A comparative evaluation of the ability of serum CA 125, CA 19-9, CA 15-3, CA 50, CA 72-4 and TATI assays in reflecting the course of disease in patients with ovarian carcinomaA Gadducci, M Ferdeghini, T Ceccarini, et al.
Pageof 11

Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
Minerva Ginecologica|March 1, 1988
[Preoperative plasma levels of von Willebrand factor in patients with cervical carcinoma]A Gadducci, U Baicchi, B Del Bravo, et al.
Gynecologic Oncology|May 1, 1996
Prothrombin fragment F1+2 and thrombin-antithrombin III complex (TAT) plasma levels in patients with gynecological cancerA Gadducci, R Marrai, U Baicchi, et al.
Annali Di Ostetricia, Ginecologia, Medicina Perinatale|July 1, 1986
[Rational bases of surgery in the therapeutic strategy for ovarian cancer]V Facchini, A Gadducci, B Del Bravo, et al.
European Journal of Gynaecological Oncology|January 1, 1986
Combined evaluation of some tumor associated antigens in the monitoring of integrated surgical and chemotherapeutic treatment of epithelial ovarian cancerP Fioretti, A Gadducci, M Ferdeghini, et al.
The Journal of Nuclear Medicine and Allied Sciences|January 1, 1989
The serum concentrations of TAG-72 antigen measured with CA 72-4 IRMA in patients with ovarian carcinoma. Preliminary dataA Gadducci, M Ferdeghini, T Ceccarini, et al.
Gynecologic Oncology|June 1, 1994
Pretreatment plasma levels of fibrinopeptide-A (FPA), D-dimer (DD), and von Willebrand factor (vWF) in patients with ovarian carcinomaA Gadducci, U Baicchi, R Marrai, et al.
European Journal of Gynaecological Oncology|January 1, 1988
The association of ultrasonography and CA-125 test in the preoperative evaluation of ovarian carcinomaA Gadducci, P Capriello, T Bartolini, et al.
Journal of Chromatography. B, Biomedical Applications|November 4, 1994
Assay and single dose pharmacokinetics of a novel systemic acyl coenzyme A cholesterol O-acyltransferase inhibitor, RP 73163, in rat plasma using automated solid-phase extraction with high-performance liquid chromatographyG D Jones, T A Hoff, P E Gunraj, et al.
European Journal of Gynaecological Oncology|January 1, 1990
A comparison of the usefulness of serum measurements of CA 125, CA 50 and TATI in patients with malignant and benign gynecological pathologyA Gadducci, M Ferdeghini, V Facchini, et al.
European Journal of Gynaecological Oncology|January 1, 1990
A comparative evaluation of the ability of serum CA 125, CA 19-9, CA 15-3, CA 50, CA 72-4 and TATI assays in reflecting the course of disease in patients with ovarian carcinomaA Gadducci, M Ferdeghini, T Ceccarini, et al.
Pageof 11